Differentiating Induced Pluripotent Stem Cells Toward Mesenchymal Stem/Stromal Cells

Methods Mol Biol. 2022:2549:153-167. doi: 10.1007/7651_2021_383.

Abstract

Differentiating human induced pluripotent stem cells (iPSCs) into multipotent mesenchymal stem/stromal cells (MSCs) offers a renewable source of therapeutically invaluable cells. However, the process of MSC derivation from iPSCs suffers from an undesirably low efficiency. In this chapter, we present an optimized procedure to produce MSCs from human iPSCs with a high efficiency. The protocol depends on the generation of embryoid bodies (EBs) and requires the treatment of EBs with transforming growth factor beta 1 (TGF-β1). The resulting MSCs can be purified based on the expression of CD73, CD105, and CD90 markers and expanded for multiple passages without losing their characteristics.

Keywords: Differentiation; Induced pluripotent stem cells; MSCs; Mesenchymal stem/stromal cells; iPSCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • Embryoid Bodies / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Mesenchymal Stem Cells* / metabolism
  • Thy-1 Antigens / metabolism

Substances

  • Thy-1 Antigens